Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-17-001230
Filing Date
2017-05-19
Accepted
2017-05-19 16:21:13
Documents
71
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q biostar10q033117.htm 10-Q 801319
2 EX-31.1 ex31-1.htm EX-31.1 14166
3 EX-31.2 ex31-2.htm EX-31.2 14377
4 EX-32.1 ex32-1.htm EX-32.1 5591
5 EX-32.2 ex32-2.htm EX-32.2 5429
  Complete submission text file 0001185185-17-001230.txt   4573851

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bspm-20170331.xml EX-101.INS 1008551
7 XBRL TAXONOMY EXTENSION SCHEMA bspm-20170331.xsd EX-101.SCH 52353
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bspm-20170331_cal.xml EX-101.CAL 31499
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bspm-20170331_def.xml EX-101.DEF 231393
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bspm-20170331_lab.xml EX-101.LAB 293137
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bspm-20170331_pre.xml EX-101.PRE 231610
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 17858096
SIC: 2834 Pharmaceutical Preparations